1 Min Read
Nov 2 (Reuters) - Aviragen Therapeutics Inc
* Aviragen Therapeutics reports first quarter of fiscal year 2018 financial results
* Q1 loss per share $0.14
* Q1 revenue $100,000 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.